Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2023-02-23 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'Q4 2022 YEAR-END REPORT' and covers the period of October–December 2022 and January–December 2022. It contains comprehensive financial statements, including net sales, operating profit, cash flow, and earnings per share, as well as detailed management commentary on performance, segment reporting, and accounting policies. It is a substantive financial report for a period shorter than a full fiscal year (in this case, a year-end report covering the final quarter and the full year), fitting the definition of an Interim/Quarterly Report. Q4 2022
2023-02-23 English
Elos Medtech adjusts dividend policy and proposes no dividend for 2022
Notice of Dividend Amount Classification · 99% confidence The document explicitly announces a decision by the board of directors to update the dividend policy and proposes that no dividend be paid for the year 2022. This content directly relates to the declaration of dividend amounts or lack thereof. Based on the provided definitions, the most specific category is 'Notice of Dividend Amount' (DIV), as it details the outcome of the dividend decision for the period.
2023-02-01 English
Elos Medtech justerar utdelningspolicy och föreslår att ingen utdelning lämnas för 2022
Notice of Dividend Amount Classification · 99% confidence The document explicitly announces a decision by the Board of Directors to update the company's dividend policy and proposes that no dividend be paid for the year 2022. This directly concerns the declaration of dividend amounts and related policy changes. Based on the provided definitions, the category 'Notice of Dividend Amount (Code: DIV)' is the most appropriate fit, as the core subject is the dividend proposal/decision for the period.
2023-02-01 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the third quarter of 2022, covering the period July-September 2022. It contains comprehensive financial statements, including income statements, cash flow data, balance sheet information, and management commentary on business performance, segments, and risks. It is not a mere announcement (RPA) as it contains the full financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report. Q3 2022
2022-10-21 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'Q3 2022 INTERIM REPORT' and contains comprehensive financial statements, key performance indicators, management commentary on business performance, and segment reporting for the period of July-September 2022. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis rather than just an announcement or certification. Q3 2022
2022-10-21 English
Elos Medtech valberedning utsedd inför årsstämman 2023
AGM Information Classification · 95% confidence The document explicitly discusses the composition and mandate of the 'valberedning' (Nomination Committee) for the upcoming 'årsstämman 2023' (Annual General Meeting 2023). It details the process for appointing committee members based on shareholder representation and lists the items the committee will propose to the AGM (e.g., election of board members, remuneration). This content is directly related to the preparation and governance surrounding the Annual General Meeting. While it mentions the AGM date, the core subject is the committee responsible for nominating candidates and setting the agenda for that meeting, which aligns best with AGM-related materials, specifically the nomination committee's role leading up to the meeting. Since there is no specific code for Nomination Committee materials, and the content is intrinsically linked to the AGM process, AGM-R (AGM Information) is the most appropriate classification, as these materials are typically shared or referenced in the context of the AGM.
2022-10-14 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.